Login
$ONAR
$0.01 +$0.00 (0.0%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current assets:
Cash
Accounts receivable
Preferred stock, value
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Preferred Stocks
Series E, Preferred Stock
Total preferred stock, value
Cash
Accounts receivable, net
House and real estate inventory
Contract assets
Prepaid expenses
Other current Assets
Investments in equity securities
Investments in equity securities, related party
Prepaid expenses and other current assets
Note receivable, current
Assets held for sale
Total current assets
Property and equipment
Intangible assets, net
Goodwill
Software costs
Note receivable, $400,700 and $-0-, due from related party, respectively
Advances to related party
Advance to affiliated entity
Advances to Affiliate
Right of use asset
Due from executive
Employee loan receivable, net
Advance to affiliated entity and related party
Note receivable
Total other assets
Total assets
Current liabilities:
Accounts payable and accrued liabilities
Accounts payable
Accrued expenses and other liabilities
Line of credit
Deferred revenue
Contract liabilities
Construction Loan
Accrued expenses and advances, related party
Lease liability
Accrued expenses, related party and advances due to executive
Notes payable
Accrued expenses, related parties
Due to executive
Notes payable, related party, net of discounts
Convertible notes payable, net of discounts
Notes payable, related party
Convertible notes payable
Convertible notes payable, net
Liabilities held for sale
Total current liabilities
Long-term note payable, net of current portion
Right-of-use liability
Total Liabilities
Common stock, 3,000,000,000 shares authorized, $0.001 par value, 231,905,314 and 140,099,049 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock, 450,000,000 shares authorized, $0.001 par value, 112,380,049 and 16,785,000 issued and outstanding as of December 31, 2024 and 2023, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support